Results 141 to 150 of about 44,917 (208)

The WEE1 inhibitor azenosertib broadly enhances efficacy of antibody-drug conjugates with topoisomerase I and microtubule inhibitor payloads. [PDF]

iScience
Guo X, Kim D, Harismendy O, Cabrera E, Chung H, Meric-Bernstam F, Lackner MR, Lee C, Ma J.   +8 more
europepmc   +1 more source

Long-Term Disease-Free Survival After Systemic-First Sequential Multimodal Therapy for Advanced and Recurrent Large-Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report. [PDF]

J Obstet Gynaecol Res
Wakana K, Akita M, Tsubata F, Kori Y, Odai T, Miyasaka N.   +5 more
europepmc   +1 more source

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study. [PDF]

BMC Cancer
Sucuoğlu İşleyen Z, Seçmeler Ş, Sakin A, Cihan Ş, Beşiroğlu M, Kahraman S, Karakurt Eryılmaz M, Zeynelgil E, Çalışkan Yıldırım E, Kut E, Şengül N, Paksoy Türköz F, Alan Ö, Özkul Ö, Işık S, Yılmaz F, Gülmez A, Türker S, Karakaya G, Günaldı M, Özer L, Aksoy A, Karataş F, Sakalar T, Demirtaş Esmer D, Teker F, Demir N, Dülgar Ö, Turhal S, Türk HM, Ertürk K, Çelik E, Atcı MM.   +32 more
europepmc   +1 more source

Metabolomic Study of 7-Ethyl-9-(<i>N</i>-methyl)aminomethyl-10-hydroxycamptothecin Derivative (NMe)-The Chemotherapeutic Drug Candidate Versus Irinotecan (IR) on a Mouse Model. [PDF]

Metabolites
Surynt P, Naumczuk B, Popławska M, Urbanowicz M, Unrug-Bielawska K, Cybulska-Lubak M, Sadowska-Markiewicz Z, Sitkowski J, Bednarek E, Zeber-Lubecka N, Kozerski L, Mikula M, Ostrowski J.   +12 more
europepmc   +1 more source

Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy. [PDF]

Adv Mater
Wade SJ, Kumar AA, Nitschke SO, Joyce P, Minaei E, Reuter SE, Penney C, Warren H, Shepherd R, Dinoro JN, Wallace GG, Dosseto A, Ansar S, Islam N, Lochhead A, Sharbeen G, Phillips PA, Aghmesheh M, Hawthorne WJ, Vine-Perrow KL.   +19 more
europepmc   +1 more source

Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single-Cell Resolution. [PDF]

Cancer Med
Pan Y, Chen L, Hu Y, Chang J, Xu X, Xu S, Li Y, Du J, Wang J, Xu W.   +9 more
europepmc   +1 more source

Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer. [PDF]

J Clin Med
Can S, Çakıcı V, Kahveci GB, Eroğlu Ş, Tok B, Uygun G, Özer E, Çırak Y, Gökmen İ.   +8 more
europepmc   +1 more source

Markers of immune activation and immunotherapy responsiveness are increased in 3D Pancreatic cancer organoids when primed with photodynamic- and chemo-therapy. [PDF]

Transl Oncol
Cabral FV, Quilez-Alburquerque J, Szoo MJ, de Silva P, Saad MA, Hasan T.   +5 more
europepmc   +1 more source

[Corrigendum] Influence of MLH1 on colon cancer sensitivity to poly(ADP‑ribose) polymerase inhibitor combined with irinotecan. [PDF]

Int J Oncol
Tentori L, Leonetti C, Muzi A, Dorio AS, Porru M, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G.   +10 more
europepmc   +1 more source

Genotyping of DPYD and UGT1A1 in Brazilian oncological patients: applying pharmacogenomics in an admixed population. [PDF]

Rev Assoc Med Bras (1992)
Cereser VHB, Moniz CMV, Suarez-Kurtz G, Estevez-Diz MDP.   +3 more
europepmc   +1 more source